Concourse Financial Group Securities, Inc. Reata Pharmaceuticals Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$79.22 - $105.37 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$22.15 - $42.11 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$19.41 - $36.49 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$20.71 - $36.5 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$24.12 - $39.6 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$25.61 - $110.96 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	SELL	$100.0 - $143.02 $16,500 - $23,598	-165 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $5,880 - $15,189	165 New	165 $13,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account